In Other News

• New Immunoassay Enables Ultrasensitive Blood-Based Tau Tangle Measurement

• Bacterial Growth Assay Predicts COVID-19 Severity From Plasma

• Blood and Urine Liquid Biopsy Detects Early Colorectal Cancer Mutations

• FDA-Approved Companion Diagnostic Detects PTEN Loss in Prostate Cancer

• Epigenetic Profiling Could Refine Prognosis in Acute Myeloid Leukemia

• Study Identifies Hereditary Subtype of Aggressive Prostate Cancer

• Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

• Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

• Blood Hormone Pattern Distinguishes Endometriosis with High Accuracy

• Epigenetic Profiling Assay Stratifies AML and Predicts Treatment Response

• Genetic Risk Score Supports Diagnosis and Prognosis in Idiopathic Pulmonary Fibrosis

• New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

• Extracellular Vesicle Marker Identifies Early Lung Adenocarcinoma and Predicts Recurrence

• CE-Marked Blood Assay Automates Tuberculosis Infection Testing

• New AI Test Delivers Rapid Breast Cancer Recurrence Predictions

• Training Device Improves Accuracy of Pooled Molecular Diagnostics

• New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

• Newly CE-Marked Blood Assay Automates Tuberculosis Infection Testing

• AI Reveals Immune Response Biomarkers Linked to Ebola Survival

• Blood Test Brings Alzheimer’s Biomarker Assessment to Routine Labs

• AI Reveals Immune Response Biomarkers Linked to Ebola Survival

• AI Decision Support System Guides Treatment Selection for Complex Blood Cancers

• WHO Adds First Bundibugyo Ebola Molecular Test to Emergency Use Listing